Alison Kodjak Alison Fitzgerald Kodjak is a health policy correspondent on NPR's Science Desk.
Alison Kodjak, photographed for NPR, 17 January 2019, in Washington DC.
Stories By

Alison Kodjak

Bull's Eye/Imagezoo/Getty Images

FDA Approval Could Turn A Free Drug For A Rare Disease Pricey

  • Download
  • <iframe src="https://www.npr.org/player/embed/460719043/460784659" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Obamacare Deadline Extended As Demand For Health Insurance Rises

  • Download
  • <iframe src="https://www.npr.org/player/embed/460312312/460312313" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Martha Lucia (from left), Bienvendida Barreno and Jorge Baquero discuss health insurance options with agents from Sunshine Life and Health Advisors at a Miami mall last month. Joe Raedle/Getty Images hide caption

toggle caption
Joe Raedle/Getty Images

Obamacare Sign-Ups Could Get A Bump As Higher Penalties Kick In

  • Download
  • <iframe src="https://www.npr.org/player/embed/459735623/459789051" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Despite Emphasis On Big Hacks, Small Breaches Of Medical Privacy Do More Harm

  • <iframe src="https://www.npr.org/player/embed/459250050/459250053" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

AIDS activists poured cat litter on an image of Turing Pharmaceuticals CEO Martin Shkreli during an October protest in New York. Craig Ruttle/AP hide caption

toggle caption
Craig Ruttle/AP

Senate Questions 'Egregious' Price Hikes For Specialty Medicines

  • <iframe src="https://www.npr.org/player/embed/458976680/459053713" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

Senate Hearings Investigate Rising Price Of Medications

  • <iframe src="https://www.npr.org/player/embed/459026284/459026285" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

While serving in Congress, Jay Dickey sponsored legislation that effectively restricts spending for research on firearms deaths. Spencer Tirey/AP hide caption

toggle caption
Spencer Tirey/AP

Congress Still Limits Health Research On Gun Violence

  • Download
  • <iframe src="https://www.npr.org/player/embed/458952821/458959474" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

A recent analysis by the Kaiser Family Foundation finds that Medicare recipients taking Revlimid for cancer could end up paying, on average, $11,538 out of pocket for the drug in 2016, even if the medicine is covered by their Medicare Part D plan. Carmine Galasso/MCT/Landov hide caption

toggle caption
Carmine Galasso/MCT/Landov

Prescription Drug Use Increased Over The Last Decade, Study Says

  • Download
  • <iframe src="https://www.npr.org/player/embed/455286418/455286419" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Aymara Marchante (from left) and Wiktor Garcia talked with Maria Elena Santa Coloma, an insurance adviser with UniVista Insurance, during February 2015 sign-ups for health plans in Miami, Fla. Joe Raedle/Getty Images hide caption

toggle caption
Joe Raedle/Getty Images

Obamacare Deploys New Apps, Allies To Persuade The Uninsured

  • Download
  • <iframe src="https://www.npr.org/player/embed/452909204/453072664" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript